Published in
American Society of Hematology, Blood Advances, 7(4), p. 1192-1196, 2020
DOI: 10.1182/bloodadvances.2019001127
Links
Tools
The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing
Journal article published in 2020 by
W. Brian Dalton 
,
Eric Helmenstine,
Lisa Pieterse,
Bing Li,
Christopher D. Gocke ,
Joshua Donaldson ,
Zhijian Xiao,
Lukasz P. Gondek,
Gabriel Ghiaur ,
Ivana Gojo,
B. Douglas Smith,
Mark J. Levis ,
Amy E. DeZern
,
Eric Helmenstine,
Lisa Pieterse,
Bing Li,
Christopher D. Gocke ,
Joshua Donaldson ,
Zhijian Xiao,
Lukasz P. Gondek,
Gabriel Ghiaur ,
Ivana Gojo,
B. Douglas Smith,
Mark J. Levis ,
Amy E. DeZern
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points The K666N mutation of SF3B1 has distinct clinicopathologic features in MDS. The K666N mutation of SF3B1 has a distinct RNA splicing profile.